Zusammenfassung
Hintergrund
Lokale Ablationsverfahren stehen in der Onkologie im Fokus aktueller Entwicklungen. Vorrangiges Ziel ist es, ohne Kompromittieren der onkologischen Ergebnisse, Organe und Organfunktionen zu erhalten.
Methode
Die irreversible Elektroporation (IRE) ist ein neues Ablationsverfahren und beruht auf einer induzierten Zellapoptose nach Applikation von Starkstromimpulsen ohne thermische Schädigung des Zielgewebes und benachbarter Strukturen.
Ziel
2005 erstmals publiziert, wird die IRE aktuell in einigen onkologischen Fachgebieten präklinischen und klinischen Untersuchungen unterzogen, die Ergebnisse sind bisher vielversprechend. Die IRE könnte eine deutliche Entwicklung in der Ablationstherapie beim Nierenzellkarzinom (NZK) bedeuten, der entscheidende Wirknachweis für das lokale NZK steht jedoch bisher aus. In dieser Arbeit werden eigene präklinische und erste klinische Untersuchungen und Ergebnisse dargestellt, diskutiert und mit anderen Ablationstechniken verglichen, um die aktuelle Wertigkeit der IRE aufzuzeigen.
Abstract
Background
Local ablation techniques are a major focus of current developments in oncology. The primary aim is to retain organs and preserve organ functions without compromising the oncological outcome.
Method
Irreversible electroporation (IRE) is a novel ablation technique that involves the application of high-voltage pulses to induce cell apoptosis without causing thermal damage to the target tissue or adjacent structures.
Aim
First published in 2005 IRE is currently undergoing preclinical and clinical trials in several areas of oncology and the initial results have been promising. The IRE technique could be a significant development in ablation treatment for renal cell carcinoma (RCC) but decisive proof of its effectiveness for local RCC has not yet been provided. This study presents the results of preclinical and initial clinical trials which are discussed and compared with those of other ablation techniques in order to demonstrate the current value of IRE.
Literatur
Ljundberg B, Cowan N, Hanbury DC et al (2010) Guidelines on renal cell carcinoma. European Association of Urology (eau) 2010, update version April 2010. Eur Urol 58(3):398–406
Lu DS, Raman SS, Vodopich DJ et al (2002) Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the „heat sink“ effect. Am J Roentgenol 178(1):47–51
Ladd AP, Rescorla FJ, Baust JG et al (1999) Cryosurgical effects on growing vessels. Am Surg 65(7):677–682
Dib RE, Touma NJ, Kapoor A (2009) Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses. Can Urol Assoc J 3(2):143–149
Duffey BG, Kyle Anderson J (2010) Current and future technology for minimally invasive ablation of renal cell carcinoma. Indian J Urol 26(3):410–417
Bischoff JT, Chen RB, Lee BR et al (1999) Laparoscopic renal cryoablation: acute and long-term clinical radiographic, and pathologic effects in an animal model and application in a clinical trial. J Endourol 13:233–239
Berger A, Kamoi K, Gill IS, Aron M (2009) Cryoablation for renal tumors: current status. Curr Opin Urol 19(2):138–142
Carrafiello G, Mangini M, Fontana F et al (2010) Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience. Cardiovasc Intervent Radiol 33(2):367–374
Brace CL (2009) Microwave ablation technology: what every user should know. Curr Probl Diagn Radiol 38(2):61–67
Klatte T, Marberger M (2009) High-intensity focused ultrasound for the treatment of renal masses: current status and future potential. Curr Opin Urol 19(2):188–191
Dick EA, Joarder R, De Jode MG et al (2002) Magnetic resonance imaging-guided laser thermal ablation of renal tumours. BJU Int 90(9):814–822
Kieran K, Hall TL, Parsons JE et al (2007) Refining histotripsy: defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney. J Urol 178:672–676
Lang EK, Sullivan J (1988) Management of primary and metastatic renal cell carcinoma by transcatheter embolization with iodine 125. Cancer 62(2):274–282
MacKie S, Silva S de, Aslan P et al (2011) Super selective radio embolization of the porcine kidney with 90yttrium resin microspheres: a feasibility, safety and dose ranging study. J Urol 185(1):285–290
Tsuchiya K, Uchida T, Kobayashi M et al (2000) Tumor-targeted chemotherapy with SMANCS in lipiodol for renal cell carcinoma:longer survival with larger size tumors. Urology 55(4):495–500
Weersink RA, Forbes J, Bisland S et al (2005) Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients. Photochem Photobiol 81(1):106–113
Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33(2):223–231
Lee EW, Wong D, Prikhodko SV et al (2012) Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. J Vasc Interv Radiol 23(1):107–113
Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality–clinical implications. Technol Cancer Res Treat 6(1):37–48
Pech M, Janitzky A, Wendler JJ et al (2012) Irreversible electroporation of renal cell carcinoma: a first-in-man phase i clinical study. Cardiovasc Intervent Radiol 35(4):921–926
Häcker A, Chauhan S, Peters K et al (2005) Multiple high-intensity focused ultrasound probes for kidney-tissue ablation. J Endourol 19(8):1036–1040
Sersa G, Jarm T, Kotnik T et al (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98(2):388–398
Lee EW, Loh CT, Kee ST (2007) Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat 6(4):287–294
Wendler JJ, Pech M, Blaschke S et al (2012) Angiography in the isolated perfused kidney: radiological evaluation of vascular protection in tissue ablation by nonthermal irreversible electroporation. Cardiovasc Intervent Radiol 35(2):383–390
Wendler JJ, Porsch M, Hühne S et al (2012) Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model. Cardiovasc Intervent Radiol (Epub ahead of print)
Aaronson NK et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–76
Wendler JJ, Pech M, Porsch M et al (2012) Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology. Cardiovasc Intervent Radiol 35(4):921–926
Vadim V, Fedorov VV, Nikolski VP, Efimov R (2008) Effect of electroporation on cardiac electrophysiology. In: Shulin Li (ed) Electroporation protocols – preclinical and clinical gene medicine, 1. edn. Humana Press, New York, pp 433–448
Mali B, Jarm T, Corovic S et al (2008) The effect of electroporation pulses on functioning of the heart. Med Biol Eng Comput 46(8):745–757
Arena C, Sano MB, Rossmeisl JH Jr et al (2011) High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle Contraction. Bio Med Eng 10:102
Ball C, Thomson KR, Kavnoudias H (2010) Irreversible electroporation: a new challenge in „out of operating theater“ anesthesia. Anesth Analg 110(5):1305–1309
Interessenskonflikte
Der korrespondierende Autor gibt für sich und seine Koautoren an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liehr, UB., Wendler, J., Blaschke, S. et al. Irreversible Elektroporation. Urologe 51, 1728–1734 (2012). https://doi.org/10.1007/s00120-012-3038-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-012-3038-8
Schlüsselwörter
- Elektroporation, irreversible
- Nierenzellkarzinom
- Ablationsverfahren, lokale
- Funktionserhalt
- Zellapoptose, induzierte